Purple Biotech (PPBT) reported Q1 earnings per share (EPS) of -$, beating estimates of -$ by %. In the same quarter last year, Purple. Purple Biotech Stock (NASDAQ: PPBT) stock price, news, charts, stock research, profile. Open, -. Close, -. Purple Biotech (NASDAQ/TASE: PPBT), a clinical-stage oncology company, has received a day extension from Nasdaq to regain compliance with the minimum $ View Purple Biotech (PPBT) stock price, news, historical charts, analyst ratings, financial information and quotes on Moomoo. Trade commission-free with the. Purple Biotech Ltd - Depositary Receipt (Common Stock) (US:PPBT) has 23 institutional owners and shareholders that have filed 13D/G or 13F forms with the.
PPBT Stock Performance ; Previous close, ; Day range, - ; Year range, 0 - 1 ; Market cap, 12,, ; Primary exchange, NASDAQ. Get the latest Purple Biotech Ltd (PPBT) real-time quote, historical performance, charts, and other financial information to help you make more informed. Purple Biotech Ltd. (NASDAQ/TASE: PPBT) is a clinical-stage company committed to the development of first-in-class, effective therapies. Find the latest Purple Biotech (PPBT) stock forecast, month price target, predictions and analyst recommendations. On average, Wall Street analysts predict that Purple Biotech's share price could reach $ by Aug 19, The average Purple Biotech stock price prediction. Track Purple Biotech Ltd - ADR (PPBT) Stock Price, Quote, latest community messages, chart, news and other stock related information. Purple Biotech Ltd PPBT:NASDAQ · Open · Day High · Day Low · Prev Close · 52 Week High · 52 Week High Date10/23/23 · 52 Week Low · Purple Biotech Ltd is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker PPBT. The last closing price for Purple Biotech was $ Over. Purple Biotech Ltd. ADR ; Average Recommendation, Buy ; Average Target Price, ; Number Of Ratings, 2 ; FY Report Date, 12/ ; Last Quarter's Earnings, The current price of PPBT is ILA — it has decreased by −% in the past 24 hours. Watch PURPLE BIOTECH stock price performance more closely on the chart.
The share price of Purple Biotech Ltd - Depositary Receipt (Common Stock) as of August 13, is $ / share. This is an increase of % from the. Purple Biotech Ltd. is a development stage pharmaceutical company, which engages in drug development. It operates through two segments: Oncology, and Pain &. See the latest Purple Biotech Ltd ADR stock price (PPBT:XNAS), related news, valuation, dividends and more to help you make your investing decisions. Purple Biotech Ltd. ADR ; P/E Ratio (TTM), N/A ; Dividend Yield, N/A ; Latest Dividend, N/A ; Ex-Dividend Date, N/A ; Beta, View Purple Biotech Ltd. Sponsored ADR PPBT stock quote prices, financial information, real-time forecasts, and company news from CNN. Purple Biotech Price Target Maintained With a $/Share by HC Wainwright & Co. Purple Biotech Shares Are Trading Lower After the Company Announced the. Purple Biotech has % upside potential, based on the analysts' average price target. Purple Biotech has a consensus rating of Moderate Buy which is based. PPBT Purple Biotech Ltd - ADR. 9, $ $ (%). Today. Watchers, 9, Wk Low, $ Wk High, $ Market Cap, $M. Purple Biotech Ltd. ; Volume, K ; Market Value, ₪M ; Shares Outstanding, M ; EPS (TTM), -₪ ; P/E Ratio (TTM), N/A.
Valuation: Purple Biotech Ltd ; P/E ratio * · EV / Sales * · Yield *. Discover real-time Purple Biotech Ltd. American Depositary Shares (PPBT) stock prices, quotes, historical data, news, and Insights for informed trading and. Purple Biotech (PPBT) has a Smart Score of N/A based on an analysis of 8 unique data sets, including Analyst Recommendations, Crowd Wisdom, and Hedge Fund. Purple Biotech Ltd is a clinical-stage company focused on advancing first-in-class therapies to overcome tumor immune evasion and drug resistance, and to create. Get the latest updates on Purple Biotech Ltd. American Depositary Shares (PPBT) after hours trades, after hours share volumes, and more.